Total Payments
$1,954
2024 Payments
$395.33
Companies
20
Transactions
129
Medicare Patients
4,241
Medicare Billing
$168,730
Payment Breakdown by Category
Food & Beverage$1,954 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,954 | 129 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $599.42 | 35 | $0 (2024) |
| Novo Nordisk Inc | $245.51 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $217.84 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $156.16 | 11 | $0 (2024) |
| PFIZER INC. | $131.88 | 9 | $0 (2023) |
| Lilly USA, LLC | $121.26 | 7 | $0 (2023) |
| Amgen Inc. | $88.14 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $80.65 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.37 | 3 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $36.93 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $395.33 | 23 | ABBVIE INC. ($141.65) |
| 2023 | $457.72 | 28 | ABBVIE INC. ($200.64) |
| 2022 | $668.87 | 49 | ABBVIE INC. ($208.12) |
| 2021 | $432.06 | 29 | PFIZER INC. ($61.36) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Gastroenterology | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/19/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Respiratory | ||||||
| 06/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 04/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Inflammation | ||||||
| 04/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Gastroenterology | ||||||
| 03/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Inflammation | ||||||
| 02/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,042 | 1,591 | $133,221 | $47,529 |
| 2022 | 31 | 1,069 | 1,971 | $127,194 | $43,179 |
| 2021 | 23 | 878 | 1,522 | $94,188 | $33,769 |
| 2020 | 30 | 1,252 | 2,263 | $133,589 | $44,253 |
Total Patients
4,241
Total Services
7,347
Medicare Billing
$168,730
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 169 | $38,870 | $10,206 | 26.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $14,787 | $8,477 | 57.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 117 | $18,486 | $5,614 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 54 | 54 | $17,820 | $5,475 | 30.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 22 | 22 | $8,294 | $2,827 | 34.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 68 | 119 | $4,760 | $1,959 | 41.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 67 | 118 | $3,776 | $1,548 | 41.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 73 | 134 | $2,814 | $1,387 | 49.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 164 | $2,232 | $1,350 | 60.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 32 | 41 | $2,829 | $1,189 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 35 | $1,645 | $995.40 | 60.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 97 | $2,231 | $923.44 | 41.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,457 | $881.64 | 60.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 72 | 115 | $2,185 | $875.15 | 40.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $2,530 | $834.46 | 33.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 30 | 30 | $870.00 | $613.80 | 70.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 13 | 15 | $1,455 | $606.75 | 41.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $1,050 | $300.51 | 28.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 24 | $1,392 | $211.21 | 15.2% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 12 | 14 | $504.00 | $206.92 | 41.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 15 | 23 | $483.00 | $203.32 | 42.1% |
| 83735 | Magnesium level | Office | 2023 | 24 | 30 | $480.00 | $197.10 | 41.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 28 | 33 | $1,056 | $186.78 | 17.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 29 | 34 | $442.00 | $172.72 | 39.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 46 | 61 | $366.00 | $134.20 | 36.7% |
About Caroline Mcsween, PA
Caroline Mcsween, PA is a Physician Assistant healthcare provider based in Newport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891190617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Caroline Mcsween, PA has received a total of $1,954 in payments from pharmaceutical and medical device companies, with $395.33 received in 2024. These payments were reported across 129 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,954).
As a Medicare-enrolled provider, Mcsween has provided services to 4,241 Medicare beneficiaries, totaling 7,347 services with total Medicare billing of $168,730. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Newport, TN
- Active Since 10/23/2014
- Last Updated 12/02/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1891190617
Products in Payments
- VRAYLAR (Drug) $333.01
- TRELEGY ELLIPTA (Drug) $190.74
- UBRELVY (Drug) $186.62
- Rybelsus (Drug) $126.44
- Ozempic (Drug) $119.07
- FARXIGA (Drug) $97.89
- XIFAXAN (Drug) $80.65
- Otezla (Drug) $71.37
- ELIQUIS (Drug) $70.52
- MOUNJARO (Drug) $69.45
- QULIPTA (Drug) $66.07
- PREMARIN (Drug) $61.36
- EMGALITY (Drug) $51.81
- JARDIANCE (Drug) $45.37
- BREZTRI (Drug) $41.35
- Kerendia (Drug) $36.93
- VOQUEZNA (Drug) $31.60
- ANORO ELLIPTA (Drug) $27.10
- INNOVAMATRIX AC (Device) $27.10
- Myrbetriq (Drug) $25.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Newport
Ms. Renee Desrosiers, Pa C, PA C
Physician Assistant — Payments: $6,157
Physician Assistant $6,157
Tonya Kallmeyer, Pa, PA
Physician Assistant — Payments: $3,794
Physician Assistant $3,794
Caila Nunes
Physician Assistant — Payments: $3,204
Physician Assistant $3,204
Lacie Sanderson, Pa-C, PA-C
Physician Assistant — Payments: $2,527
Physician Assistant $2,527
Evan Hewgley, Pa, PA
Physician Assistant — Payments: $1,784
Physician Assistant $1,784
Donald Campbell, Pa-C, PA-C
Physician Assistant — Payments: $1,339
Physician Assistant $1,339